{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:39:20Z","timestamp":1789486760549,"version":"build-2803163510"},"reference-count":40,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.14797\/mdcvj.1845","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:17:17Z","timestamp":1789478237000},"page":"15-21","source":"Crossref","is-referenced-by-count":0,"title":["Is the Commitment to LDL-C Eternal?"],"prefix":"10.14797","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3540-3956","authenticated-orcid":false,"given":"Allan D.","family":"Sniderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"1","key":"key20260915131709_B1","first-page":"36","article-title":"The Expert Panel","volume":"148","author":"Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"1988","journal-title":"Arch Intern Med"},{"issue":"17","key":"key20260915131709_B2","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001423","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"153","author":"Writing Committee Memebers","year":"2026","journal-title":"Circulation"},{"issue":"1","key":"key20260915131709_B3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","year":"2020","journal-title":"Eur Heart J"},{"issue":"15","key":"key20260915131709_B4","article-title":"Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol","volume":"12","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"42","key":"key20260915131709_B5","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","year":"2025","journal-title":"Eur Heart J"},{"issue":"8122","key":"key20260915131709_B6","first-page":"901","article-title":"Are apolipoproteins better discriminators than lipids for atherosclerosis?","volume":"1","year":"1979","journal-title":"Lancet"},{"issue":"1","key":"key20260915131709_B7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1073\/pnas.77.1.604","article-title":"Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]","volume":"77","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8232","key":"key20260915131709_B8","first-page":"1257","article-title":"Need for new classification of lipoprotein derangements in human atherosclerosis","volume":"1","year":"1981","journal-title":"Lancet"},{"issue":"2","key":"key20260915131709_B9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0021-9150(71)90018-9","article-title":"Apoliproproteins and lipoproteins","volume":"13","year":"1971","journal-title":"Atherosclerosis"},{"issue":"9298","key":"key20260915131709_B10","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","article-title":"High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study","volume":"358","year":"2001","journal-title":"Lancet"},{"issue":"9","key":"key20260915131709_B11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/14779072.2025.2543537","article-title":"High apoB\/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines","volume":"23","year":"2025","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9","key":"key20260915131709_B12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14779072.2025.2543535","article-title":"High apoB\/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines","volume":"23","year":"2025","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"key20260915131709_B13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel","volume":"259","year":"2006","journal-title":"J Intern Med"},{"issue":"24","key":"key20260915131709_B14","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/01.CIR.0000130646.93255.86","article-title":"Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study","volume":"109","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"key20260915131709_B15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11883-025-01289-9","article-title":"Familial Combined Hyperlipidemia: Myth or Reality?","volume":"27","year":"2025","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"key20260915131709_B16","first-page":"224","article-title":"Familial Combined Hyperlipidemia: Current Knowledge, Perspectives, and Controversies","volume":"70","year":"2018","journal-title":"Rev Invest Clin"},{"issue":"10","key":"key20260915131709_B17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9149(03)00262-5","article-title":"Concordance\/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk","volume":"91","year":"2003","journal-title":"Am J Cardiol"},{"key":"key20260915131709_B18","doi-asserted-by":"crossref","first-page":"119139","DOI":"10.1016\/j.atherosclerosis.2025.119139","article-title":"Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation","volume":"403","year":"2025","journal-title":"Atherosclerosis"},{"issue":"4","key":"key20260915131709_B19","first-page":"844","article-title":"ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk","volume":"19","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"3","key":"key20260915131709_B20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1172\/JCI112360","article-title":"Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia","volume":"77","year":"1986","journal-title":"J Clin Invest"},{"issue":"1","key":"key20260915131709_B21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-2275(20)34410-2","article-title":"Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease","volume":"26","year":"1985","journal-title":"J Lipid Res"},{"issue":"7","key":"key20260915131709_B22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","year":"1973","journal-title":"J Clin Invest"},{"issue":"2","key":"key20260915131709_B23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2362.2002.00941.x","article-title":"A proposal to redefine familial combined hyperlipidaemia -- third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation","volume":"32","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"2 Pt 1","key":"key20260915131709_B24","first-page":"346","article-title":"Committee on Nutrition. Hypoallergenic infant formulas","volume":"106","author":"American Academy of Pediatrics","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"key20260915131709_B25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1542\/peds.2007-3022","article-title":"Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas","volume":"121","author":"American Academy of Pediatrics Committee on N, American Academy of Pediatrics Section on A, Immunology","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"key20260915131709_B26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"2 Suppl","key":"key20260915131709_B27","first-page":"449S","article-title":"History of recommendations to the public about dietary fat","volume":"128","year":"1998","journal-title":"J Nutr"},{"issue":"9175","key":"key20260915131709_B28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0140-6736(98)11185-6","article-title":"Clinical trials, consensus conferences, and clinical practice","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"key20260915131709_B29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jclinepi.2012.01.009","article-title":"Pluralism of viewpoints as the antidote to intellectual conflict of interest in guidelines","volume":"65","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"key20260915131709_B30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jama.2015.6177","article-title":"The Role of Physicians in the Era of Predictive Analytics","volume":"314","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"key20260915131709_B31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2010.50","article-title":"Diagnosis and treatment of apolipoprotein B dyslipoproteinemias","volume":"6","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"key20260915131709_B32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamacardio.2024.1310","article-title":"Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels","volume":"9","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"3","key":"key20260915131709_B33","doi-asserted-by":"crossref","first-page":"100825","DOI":"10.1016\/j.jacadv.2023.100825","article-title":"The Causal-Benefit Model to Prevent Cardiovascular Events","volume":"3","year":"2024","journal-title":"JACC Adv"},{"issue":"27","key":"key20260915131709_B34","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/eurheartj\/ehae258","article-title":"Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention","volume":"45","year":"2024","journal-title":"Eur Heart J"},{"issue":"23","key":"key20260915131709_B35","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2024.03.423","article-title":"Excess Apolipoprotein B and Cardiovascular Risk in Women and Men","volume":"83","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20260915131709_B36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-025-02852-8","article-title":"Association of apolipoprotein B and excess apolipoprotein B with cardiovascular risk in type 2 diabetes: a prospective cohort study of the UK Biobank","volume":"25","year":"2026","journal-title":"Lipids Health Dis"},{"issue":"1","key":"key20260915131709_B37","first-page":"010704","article-title":"Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol","volume":"32","year":"2022","journal-title":"Biochem Med (Zagreb)"},{"issue":"1","key":"key20260915131709_B38","article-title":"Excess apolipoprotein B predicts long-term survival in statin-treated CAD irrespective of achieved LDL-C levels: a pooled cohort analysis","volume":"25","year":"2026","journal-title":"Lipids Health Dis"},{"issue":"2","key":"key20260915131709_B39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00392-025-02767-5","article-title":"Association of apolipoprotein B, excess apolipoprotein B and apoB\/apoA1 ratio with 20-year atherosclerotic cardiovascular disease risk: the ATTICA study (2002-2022)","volume":"115","year":"2026","journal-title":"Clin Res Cardiol"},{"issue":"17","key":"key20260915131709_B40","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.2026.2986","article-title":"Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy","volume":"335","year":"2026","journal-title":"JAMA"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:17:23Z","timestamp":1789478243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1845\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["10.14797\/mdcvj.1845"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1845","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}